Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Medtronic
Mallinckrodt
Express Scripts
Harvard Business School

Last Updated: December 7, 2021

Volunteer for clinical trials for TESTOSTERONE ENANTHATE at ClinicalTrialExchange

DrugPatentWatch Database Preview

TESTOSTERONE ENANTHATE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Testosterone Enanthate, and what generic alternatives are available?

Testosterone Enanthate is a drug marketed by Hikma Farmaceutica, Mylan Institutional, Nexus Pharms, Watson Labs, and Watson Pharms Inc. and is included in eight NDAs.

The generic ingredient in TESTOSTERONE ENANTHATE is estradiol valerate; testosterone enanthate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol valerate; testosterone enanthate profile page.

Drug patent expirations by year for TESTOSTERONE ENANTHATE
Drug Prices for TESTOSTERONE ENANTHATE

See drug prices for TESTOSTERONE ENANTHATE

Recent Clinical Trials for TESTOSTERONE ENANTHATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The University of Texas Medical Branch, GalvestonPhase 2/Phase 3
University of FloridaPhase 2
North Florida/South Georgia Veterans Health SystemPhase 2

See all TESTOSTERONE ENANTHATE clinical trials

Pharmacology for TESTOSTERONE ENANTHATE
Drug ClassAndrogen
Mechanism of ActionAndrogen Receptor Agonists

US Patents and Regulatory Information for TESTOSTERONE ENANTHATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma Farmaceutica TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 091120-001 Sep 18, 2012 AO RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Pharms Inc TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 085598-001 Approved Prior to Jan 1, 1982 AO RX No Yes ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Watson Labs TESTOSTERONE ENANTHATE testosterone enanthate INJECTABLE;INJECTION 083667-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
AstraZeneca
Johnson and Johnson
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.